S&P 500 (NYSE:SPY) component Eli Lilly & Co (NYSE:LLY) will unveil its latest earnings tomorrow, Tuesday, January 29, 2013. Eli Lilly develops and manufactures pharmaceutical products as well as animal health products.
Eli Lilly & Co Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for profit of 78 cents per share, a decline of 10.3% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 82 cents. Between one and three months ago, the average estimate moved up. It has dropped from 83 cents during the last month. For the year, analysts are projecting net income of $3.33 per share, a decline of 24.5% from last year.
Past Earnings Performance: The company missed estimates last quarter after beating forecasts in the prior two. In the third quarter, the company reported profit of 79 cents per share versus a mean estimate of net income of 83 cents per share. In the second quarter, the company beat estimates by 6 cents.
Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!
A Look Back: In the third quarter, profit rose 7.3% to $1.33 billion ($1.18 a share) from $1.24 billion ($1.11 a share) the year earlier, but fell short analyst expectations. Revenue fell 11.5% to $5.44 billion from $6.15 billion.
Here’s how Eli Lilly & Co traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week: